This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Rheumatoid Arthritis, Influenza or Methotrexate
and you are
between 18 and 65
years old
-
The phase for this study is not defined.
Show me locations

The purpose

To investigate whether a transient discontinuation of methotrexate MTX for 2 weeks improves the vaccination response to a seasonal influenza.

Provided treatments

  • Drug: Methotrexate

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02897011. The sponsor of the trial is Seoul National University Hospital and it is looking for 318 volunteers for the current phase.
Official trial title:
Effect of Two-week Discontinuation of Methotrexate on Efficacy of Seasonal Influenza Vaccination in Patients With Rheumatoid Arthritis: A Randomized Clinical Trial